Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Sadia Rahman
WF
Sadia Rahman
Wall Street Analyst
★★★☆☆
#1317
on 13Foresight · ranked by our own returns
33%
Success Rate
-4.3%
Average Return
2 of 6 calls profitable · -6.7% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 33% of Sadia Rahman's ratings turned a profit when each position was held for 1 year — averaging -4.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

11 Buy 0 Hold 0 Sell
Sadia's Stock Coverage 3 ratings · 2026-06-19
Company Date Position Consensus Price Target 1-Yr Return
DNTH
Dianthus Therapeutics
Jun 17, 2026 BUY Strong Buy
+8.9% avg upside
29 analysts
$135.00
63.58% Upside
·
VOR
Vor Biopharma
May 13, 2026 BUY Buy
+199.3% avg upside
17 analysts
$30.00
107.10% Upside
-11.6%
MAZE
Maze Therapeutics, Inc.
May 13, 2026 BUY Strong Buy
+145.3% avg upside
12 analysts
$55.00
114.27% Upside
-7.9%
Sadia Rahman — Frequently Asked Questions
How accurate are Sadia Rahman's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Sadia's ratings were profitable over a one-year hold, with an average return of -4.3% per rating, or -6.7% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Sadia ranked on 13Foresight?
Sadia Rahman is currently ranked #1317 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Sadia cover?
Sadia most recently has ratings on DNTH, VOR, MAZE. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.